Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer.

Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer. NPJ Breast Cancer. 2018; 4:22.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.